Cargando…

The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study

OBJECTIVE: This study sought to investigate an association of HbA1c (A1C) with incident heart failure among individuals without diabetes and compare it to fasting glucose. RESEARCH DESIGN AND METHODS: We studied 11,057 participants of the Atherosclerosis Risk in Communities (ARIC) Study without hear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsushita, Kunihiro, Blecker, Saul, Pazin-Filho, Antonio, Bertoni, Alain, Chang, Patricia P., Coresh, Josef, Selvin, Elizabeth
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911067/ https://www.ncbi.nlm.nih.gov/pubmed/20484138 http://dx.doi.org/10.2337/db10-0165

Ejemplares similares

Glycated Hemoglobin and the Risk of Kidney Disease and Retinopathy in Adults With and Without Diabetes
por: Selvin, Elizabeth, et al.
Publicado: (2011)

Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
por: Selvin, Elizabeth, et al.
Publicado: (2016)

New Diabetes Diagnostic Threshold of Hemoglobin A(1c) and the 3-Year Incidence of Retinopathy
por: Tsugawa, Yusuke, et al.
Publicado: (2012)

Ankle-brachial index and incident diabetes mellitus: the atherosclerosis risk in communities (ARIC) study
por: Hua, Simin, et al.
Publicado: (2016)

Diabetes and Risk of Fracture-Related Hospitalization: The Atherosclerosis Risk in Communities Study
por: Schneider, Andrea L.C., et al.
Publicado: (2013)

Hyperhomocysteinemia Potentiates Hyperglycemia-Induced Inflammatory Monocyte Differentiation and Atherosclerosis
por: Fang, Pu, et al.
Publicado: (2014)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission
por: Wang, Qilong, et al.
Publicado: (2017)

Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study
por: Ishigami, Junichi, et al.
Publicado: (2018)

Silence of TRIB3 Suppresses Atherosclerosis and Stabilizes Plaques in Diabetic ApoE(−/−)/LDL Receptor(−/−) Mice
por: Wang, Zhi-hao, et al.
Publicado: (2012)

Vessel Shrinkage as a Sign of Atherosclerosis Progression in Type 2 Diabetes : A Serial Intravascular Ultrasound Analysis
por: Jiménez-Quevedo, Pilar, et al.
Publicado: (2009)

Glycated Hemoglobin and Risk of Hypertension in the Atherosclerosis Risk in Communities Study
por: Bower, Julie K., et al.
Publicado: (2012)

Increasing Circulating IGFBP1 Levels Improves Insulin Sensitivity, Promotes Nitric Oxide Production, Lowers Blood Pressure, and Protects Against Atherosclerosis
por: Rajwani, Adil, et al.
Publicado: (2012)

Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
por: Genuth, Saul, et al.
Publicado: (2015)

Adrenergic Mediation of Hypoglycemia-Associated Autonomic Failure
por: Ramanathan, Ranjani, et al.
Publicado: (2011)

Socioeconomic Status and Incidence of Hospitalization With Lower‐Extremity Peripheral Artery Disease: Atherosclerosis Risk in Communities Study
por: Vart, Priya, et al.
Publicado: (2017)

Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008–2012: association with hemoglobin A (1c) and treatment modality
por: Birkebaek, NH, et al.
Publicado: (2017)

Consistent Effects of Hypoglycemia on Cognitive Function in People With or Without Diabetes
por: Verhulst, Clementine E.M., et al.
Publicado: (2022)

A Novel Cellular Defect in Diabetes: Membrane Repair Failure
por: Howard, Amber C., et al.
Publicado: (2011)

Opioid Receptor Blockade Prevents Exercise-Associated Autonomic Failure in Humans
por: Milman, Sofiya, et al.
Publicado: (2012)

Accelerated Progression From Mild Cognitive Impairment to Dementia in People With Diabetes
por: Xu, Weili, et al.
Publicado: (2010)

Endothelial dysfunction and the risk of heart failure in a community‐based study: the Multi‐Ethnic Study of Atherosclerosis
por: Ärnlöv, Johan, et al.
Publicado: (2020)

APOL1 Risk Alleles, Cardiac Markers, and Risk of ESKD in African Americans: The Atherosclerosis Risk in Communities Study
por: Surapaneni, Aditya L., et al.
Publicado: (2020)

Trends in Incidence of Type 1 Diabetes Among Non-Hispanic White Youth in the U.S., 2002–2009
por: Lawrence, Jean M., et al.
Publicado: (2014)

Cell-Based Screening Identifies Paroxetine as an Inhibitor of Diabetic Endothelial Dysfunction
por: Gerö, Domokos, et al.
Publicado: (2013)

Resting-State Brain Networks in Type 1 Diabetic Patients With and Without Microangiopathy and Their Relation to Cognitive Functions and Disease Variables
por: van Duinkerken, Eelco, et al.
Publicado: (2012)

Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes
por: Miao, Feng, et al.
Publicado: (2014)

Association of Peripheral Artery Disease With Incident Atrial Fibrillation: The ARIC (Atherosclerosis Risk in Communities) Study
por: Bekwelem, Wobo, et al.
Publicado: (2018)

Activation of Peroxisome Proliferator–Activated Receptor δ Inhibits Streptozotocin-Induced Diabetic Nephropathy Through Anti-Inflammatory Mechanisms in Mice
por: Matsushita, Yuichi, et al.
Publicado: (2011)

Insulin Resistance, Defective Insulin-Mediated Fatty Acid Suppression, and Coronary Artery Calcification in Subjects With and Without Type 1 Diabetes: The CACTI Study
por: Schauer, Irene E., et al.
Publicado: (2011)

Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-Year Follow-Up Study
por: Nin, Johanna W.M., et al.
Publicado: (2010)

Growth Differentiation Factor 15 and Risk of Bleeding Events: The Atherosclerosis Risk in Communities Study
por: Mathews, Lena, et al.
Publicado: (2023)

Response to Comment on: Selvin et al. No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes. Diabetes Care 2013;36:2995–3001
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
por: Lutsey, Pamela L., et al.
Publicado: (2014)

Bone turnover and metabolite responses to exercise in people with and without long-duration type 1 diabetes: a case–control study
por: Taylor, Guy S, et al.
Publicado: (2020)

α1-Acid Glycoprotein Decreases Neutrophil Migration and Increases Susceptibility to Sepsis in Diabetic Mice
por: Spiller, Fernando, et al.
Publicado: (2012)

Effectiveness of at-home skin temperature monitoring in reducing the incidence of foot ulcer recurrence in people with diabetes: a multicenter randomized controlled trial (DIATEMP)
por: Bus, Sicco A, et al.
Publicado: (2021)

No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes
por: Selvin, Elizabeth, et al.
Publicado: (2013)

CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes
por: Teng, Beina, et al.
Publicado: (2016)

High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study
por: Whelton, Seamus P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dl2hn6b95ruf8ggve52rmnlk1a